Novo says the Denver data, Nov. 5 to 9, include a real-world comparison of Wegovy 2.4 mg and resmetirom in MASH patients, picked as a Poster of Distinction.
Recap by typeshit. Full story at BioSpace.
Trials show large weight loss on semaglutide, and medical attention is shifting to the health effects that come with it.
Doctors at the Kenya launch of Ozempic and Wegovy cited SELECT and FLOW trial results, while warning that long-term liver evidence is still unsettled.
A new Journal of the American Chemical Society study describes a solid-state method for finding and quantifying peptide biomarkers in diluted human serum.
36:35
Lyle McDonald digs into the claim that Lilly's experimental drug burns more energy, and says the answer won't please everyone.
Time reports Hims stock rose 5% after the policy, while critics including Americans for Safe and Effective Medicines warn consumers are being treated like test subjects.
A short social share with no study or source named, flagging possible nutrient shortfalls for people on weight loss shots.
Loading…